Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Edan

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2008
The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosisN De Stefano, M Filippi, C Confavreux, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1997
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteriaG Edan, D Miller, M Clanet, et al.
Revue Neurologique|October 22, 2013
[Cavitary lesions in multiple sclerosis: multicenter study on twenty patients]A Corlobé, D Renard, C Goizet, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 16, 2011
Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosisS Acaster, P Swinburn, C Wang, et al.
Bone Marrow Transplantation|November 2, 2004
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosisR Saccardi, A Tyndall, G Coghlan, et al.
Annals of Neurology|July 18, 2001
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosisW I McDonald, A Compston, G Edan, et al.
American Journal of Human Genetics|October 21, 2004
A second-generation genomic screen for multiple sclerosisS J Kenealy, M-C Babron, Y Bradford, et al.
Genes and Immunity|March 21, 2008
IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populationsF Weber, B Fontaine, I Cournu-Rebeix, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosisJ Kuhle, M Hardmeier, G Disanto, et al.
Journal of Neurology|July 29, 2018
Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patientsG Balloy, J Pelletier, L Suchet, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2008
The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosisN De Stefano, M Filippi, C Confavreux, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1997
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteriaG Edan, D Miller, M Clanet, et al.
Revue Neurologique|October 22, 2013
[Cavitary lesions in multiple sclerosis: multicenter study on twenty patients]A Corlobé, D Renard, C Goizet, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 16, 2011
Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosisS Acaster, P Swinburn, C Wang, et al.
Bone Marrow Transplantation|November 2, 2004
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosisR Saccardi, A Tyndall, G Coghlan, et al.
Annals of Neurology|July 18, 2001
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosisW I McDonald, A Compston, G Edan, et al.
American Journal of Human Genetics|October 21, 2004
A second-generation genomic screen for multiple sclerosisS J Kenealy, M-C Babron, Y Bradford, et al.
Genes and Immunity|March 21, 2008
IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populationsF Weber, B Fontaine, I Cournu-Rebeix, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosisJ Kuhle, M Hardmeier, G Disanto, et al.
Journal of Neurology|July 29, 2018
Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patientsG Balloy, J Pelletier, L Suchet, et al.
Pageof 13